Senior insider sale
EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$3.55M
7.35K shares
What this filing means
MCKECHNIE DUNCAN plans to sell 7.35K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $3.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001959173-26-001862
Officer· EVP, Chief Commercial Officer
Since Mar 2026
7.35K
Shares to sell
$3.55M
Approx. market value
2.44K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
2.44KTotal acquired2.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 2.44K | — |
| Total | 2.44K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.91K
Market value
$2.39M
2/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.44K
Market value
$1.16M
3/4/2026
Total
Units
7.35K
Value
$3.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2026 | 4.91K | $2.39M | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 2.44K | $1.16M | NASDAQ | Planned |
| Total | 7.35K | $3.55M | ||